Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer

Surgical Clinics of North America

Volumn 83, Issue 4, 2003, Pages 911-930

  Buchholz, Thomas A ^a   Strom, Eric A ^a   McNeese, Marsha D ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; BREAST CARCINOMA; BREAST METASTASIS; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MASTECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0038156997     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00048-3     Document Type: Review

References (59)

1. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220(3):391-8.
2. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88(3):608-14.
3. Bergkvist J, Frisell G, Liljegren F, et al. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001;88:1644-8.
4. Dupont E, Cox C, Shivers S, et al. Learning curves and breast cancer lymphatic mapping: institutional volume index. J Surg Res 2001;97:92-6.
5. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15(6):2345-50.
6. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229(4):528-35.
7. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339(14):941-6.
8. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18(13):2560-6.
9. O'Hea BJ, Hill AD, El-Shirbiny AM. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186(4):423-7.
10. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233(1):51-9.
11. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91(4):368-73.
12. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234(3):292-300.
13. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 2001;182(4):347-50.
14. Tafra L, McMasters KM, Whitworth P, et al. Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 2000;180(4):268-73.
15. Lucci A Jr., Kelemen PR, Miller C, et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192(4):453-8.
16. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18(20):3480-6.
17. Fisher B, Montague E, Redmond C, et al. Findings from NSABP Protocol No. B-04 - comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome. Cancer 1980;46(1):1-13.
18. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312(11):674-81.
19. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
20. Overgaard M, Hansen S, Rose P, et al. Randomized trial evaluating postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: results from the DBCG 82c trial. Lancet 1999;353:1641-8.
21. Overgaard M, Christensen JJ, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990;19(5):1121-4.
22. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Onc 1999;6(1):109-16.
23. Haffty BG, McKhann C, Beinfield, et al. Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients. Arch Surg 1993;128(12):1315-9.
24. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993;26(4):593-9.
25. Hoebers FJ, Borger JH, Hart AA. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer 2000;88(7):1633-42.
26. Kuznetsova M, Graybill JC, Zusag TW, et al. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome. Radiology 1995;197(2):507-10.
27. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9(6):988-96.
28. Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994;74(3):878-83.
29. Wong JS, Recht A, Beard CJ, et al. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Rad Onc Biol Phys 1997;39(4):915-20.
30. Zurrida S, Orecchia R, Galimberti V, et al. Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol 2002;9(2):156-60.
31. Aristei C, Chionne F, Marsella AR, et al. Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: results of a prospective study. Int J Radiat Oncol Biol Phys 2001;51(1):69-73.
32. Goodman RL, Grann A, Saracco P, et al. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast. Int J Radiat Oncol Biol Phys 2001;50(1):99-105.
33. Kiel KD, Chang S, Small W, et al. Is it possible to treat the axillary nodes in the same radiation fields covering the breast? A study to locate the limits of the axillary dissection relative to anatomic landmarks in the tangential fields. Int J Rad Onc Biol Phys 1997;39(2):264.
34. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 2001;51(3):671-8.
35. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18(13):2553-9.
36. Hwang RF, Krishnamurthy S, Hunt KK. Clinicopathological factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003;10(3):248-54.
37. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17(6):1720-6.
38. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89(3):574-81.
39. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229(4):536-41.
40. Galper S, Recht A, Silver B, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45(5):1157-66.
41. Galper S, Recht A, Silver B, et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys 2000;48(1):125-32.
42. Byrd DR, Dunwald LK, Mankoff DA, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 2001;8(3):234-40.
43. Haigh PI, Hansen NM, Giuliano AE, et al. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 2000;41(10):1682-8.
44. Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 2000;179:386-8.
45. Laronga C, Ross M, Alderfer J, et al. Tumor location and nodal drainage patterns on lymphoscintigraphy are predictors of axillary sentinel lymph node status. Proc Amer Soc Clin Oncol 2001;20:40a.
46. Smitt MC, Bevan A, Strauss HW, et al. Patterns of internal mammary drainage during sentinel node lymphoscintigraphy. Breast Can Res Treat 2000;64(1):40.
47. Uren RF, Howman-Giles R, Renwick SB, et al. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg 2001;25(6):789-93.
48. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-80.
49. Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977;39:533-8.
50. Handley RS. Carcinoma of the breast. Ann R Coll Surg Engl 1975;57:59-66.
51. Livingston SF, Arlen M. The extended extrapleural radical mastectomy: its role in the treatment of carcinoma of the breast. Ann Surg 1974;179:260-5.
52. Urban JA, Marjani MA. Significance of internal mammary lymph node metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med 1971;3:130-6.
53. Galimberti V, Arnone P, Pesci Feltri A, et al. Stage migration in breast cancer after biopsy of the internal mammary lymph nodes. Eur J Cancer 2001;37(Suppl 6):S270.
54. Dupont EL, Salud CJ, Peltz ES, et al. Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 2001;182(4):321-4.
55. Le MG, Arriagada R, de Vathaire F, et al. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive lymph nodes? Cancer 1990;66:2313-8.
56. Zucali R, Luigi M, Ettore M, et al. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 1998;16:1363-6.
57. Gaffney DK, Tsodikov A, Wiggins CL. Diminished overall survival in patients with inner versus outer quadrant breast cancer. Int J Rad Oncol Biol Phys 2001;51(Suppl 1):111.
58. Sixel KE, Aznar MC, Ung YC. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 2001;49(1):199-204.
59. Dupont E, Cox CE, Nguyen K, et al. Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 2001;8(10):833-6.